Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer.
Buglione M, Maddalo M, Corvò R, Pirtoli L, Paiar F, Lastrucci L, Stefanacci M, Belgioia L, Crociani M, Vecchio S, Bonomo P, Bertocci S, Borghetti P, Pasinetti N, Triggiani L, Costa L, Tonoli S, Grisanti S, Magrini SM. Buglione M, et al. Among authors: pasinetti n. Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):462-472. doi: 10.1016/j.ijrobp.2016.10.011. Epub 2016 Oct 20. Int J Radiat Oncol Biol Phys. 2017. PMID: 27986347 Clinical Trial.
The impact of tumour histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients.
Buglione M, Bandera L, Grisanti S, Pasinetti N, Borghetti P, Barbera F, Triggiani L, Costa L, Shehi B, Bonetti B, Magrini S. Buglione M, et al. Among authors: pasinetti n. Radiol Med. 2012 Feb;117(1):133-47. doi: 10.1007/s11547-011-0738-x. Epub 2011 Oct 21. Radiol Med. 2012. PMID: 22020431 English, Italian.
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part I: Evolving technical choices and survival.
Tonoli S, Magrini SM, Costa L, Paiar F, Simontacchi G, Scotti V, Pasinetti N, Barca R, Barbieri D, De Stefani A, Cellai E, Buglione M, Biti G. Tonoli S, et al. Among authors: pasinetti n. Radiol Med. 2012 Jun;117(4):690-714. doi: 10.1007/s11547-011-0755-9. Epub 2011 Nov 17. Radiol Med. 2012. PMID: 22095424
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part II: Evolving technical choices and toxicity patterns.
Magrini SM, Tonoli S, Costa L, Pasinetti N, Paiar F, Livi L, Simontacchi G, Meattini I, Pegurri L, Borghetti P, Frata P, Ponticelli P, Buglione M, Biti G. Magrini SM, et al. Among authors: pasinetti n. Radiol Med. 2012 Jun;117(4):715-24. doi: 10.1007/s11547-011-0756-8. Epub 2011 Nov 17. Radiol Med. 2012. PMID: 22095425
Circulating tumour cells in locally advanced head and neck cancer: preliminary report about their possible role in predicting response to non-surgical treatment and survival.
Buglione M, Grisanti S, Almici C, Mangoni M, Polli C, Consoli F, Verardi R, Costa L, Paiar F, Pasinetti N, Bolzoni A, Marini M, Simoncini E, Nicolai P, Biti G, Magrini SM. Buglione M, et al. Among authors: pasinetti n. Eur J Cancer. 2012 Nov;48(16):3019-26. doi: 10.1016/j.ejca.2012.05.007. Epub 2012 Jun 7. Eur J Cancer. 2012. PMID: 22682019
Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk.
Buglione M, Spiazzi L, Saiani F, Costa L, Shehi B, Lazzari B, Uccelli C, Pasinetti N, Borghetti P, Triggiani L, Donadoni L, Pedretti S, Magrini SM; Neuro-Oncology Group, Spedali Civili, Brescia University, Brescia, Italy. Buglione M, et al. Among authors: pasinetti n. Tumori. 2014 May-Jun;100(3):272-7. doi: 10.1700/1578.17200. Tumori. 2014. PMID: 25076237
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage I and II disease.
Buglione M, Pedretti S, Costa L, Foscarini F, Maddalo M, Pegurri L, Pasinetti N, Ciccarelli S, Tonoli S, Magrini SM. Buglione M, et al. Among authors: pasinetti n. Radiol Med. 2015 Nov;120(11):1071-7. doi: 10.1007/s11547-015-0533-1. Epub 2015 Mar 28. Radiol Med. 2015. PMID: 25820354
56 results